Evidence map›Paper›PMID 40492464›Full record

ArticleMolecular pharmaceutics2025

Optimized Artificial Colonic Mucus Enabling Physiologically Relevant Diffusion Studies of Drugs, Particles, and Delivery Systems.

Marco Tjakra, Nopdanai Chakrapeesirisuk, Magdalena Jacobson, Mikael E Sellin, Jens Eriksson, Alexandra Teleki, Christel A S Bergström

Abstract read
In one paragraph

Article in Molecular pharmaceutics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Marco TjakraDepartment of Pharmacy, Uppsala Biomedical Center, Uppsala University, 751 23 Uppsala, Sweden.ORCID 0000-0003-2266-4011
Nopdanai ChakrapeesirisukDepartment of Pharmacy, Uppsala Biomedical Center, Uppsala University, 751 23 Uppsala, Sweden.
Magdalena JacobsonDepartment of Clinical Sciences, Faculty of Veterinary Medicine and Animal Science, Swedish University of Agricultural Sciences, Box 7054, SE-750 07 Uppsala, Sweden.
Mikael E SellinDepartment of Medical Biochemistry and Microbiology, Uppsala University, 751 23 Uppsala, Sweden.
Jens ErikssonDepartment of Medical Biochemistry and Microbiology, Uppsala University, 751 23 Uppsala, Sweden.
Alexandra TelekiDepartment of Pharmacy, Uppsala Biomedical Center, Uppsala University, 751 23 Uppsala, Sweden.ORCID 0000-0001-6514-8960
Christel A S BergströmDepartment of Pharmacy, Uppsala Biomedical Center, Uppsala University, 751 23 Uppsala, Sweden.ORCID 0000-0002-8917-2612

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Development of oral drug delivery systems that penetrate the colonic mucus remains challenging. Artificial models of porcine colonic mucus have been developed that mimic the rheology and viscosity of the native mucus and its contents of mucins, protein, and lipids. However, they are less representative with regard to the zeta potential, a factor of importance for charged molecules and particles. This study therefore aimed to improve the existing porcine artificial colonic mucus model by exchanging the polymer backbone (used for viscosity) to more closely mimic the charge of porcine native colonic mucus. Polymers studied were poly(acrylic acid), hydroxyethylcellulose, sodium hyaluronate, sodium alginate, and pectin. The resulting porcine artificial colonic mucus was assayed for apparent viscosity, storage modulus, pH, water content, zeta potential, and pore size. The two best-performing polymers (poly(acrylic acid) and hydroxyethylcellulose) were then assayed with diffusion of FITC-dextran, particle tracking of nanoparticles, and binding of FITC-dextran and contrasted to data generated in porcine native colonic mucus (PNCM). Of the two polymers, PACM based on HEC generated zeta potential and binding kinetics similar to those of PNCM. We conclude that the choice of polymer in PACMs is critical for improving their use in drug development. The extensive characterization of the PACMs further points toward the importance of complementary techniques to determine rheological characteristics, mesh, and pore size.

Indexed as

ColonDrug Delivery SystemsMucusAcrylic ResinsAlginatesAnimalsCelluloseDextransDiffusionFluorescein-5-isothiocyanateIntestinal MucosaNanoparticlesPolymersRheologySwineViscosityAcrylic ResinsAlginatescarbopol 940CelluloseDextransFluorescein-5-isothiocyanatefluorescein isothiocyanate dextranhydroxyethylcellulosePolymersbindingcolondiffusiondrugdrug deliveryhydrogelmucusrheologystructure

Identifiers

PMID40492464
PMCPMC12239078

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.